7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis. 1985

M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell

In an effort to obtain more information on the structure-activity relationship among the 7 alpha-(phenylthio)androstenedione inhibitors of the enzyme aromatase, a series of compounds containing both electron-donating and electron-withdrawing ring substituents was synthesized and tested for aromatase inhibitory activity. No linear correlation between substituent electronic effects and inhibitory activity was observed. The halogen-containing compounds, particularly 8, appeared to be quite potent inhibitors. The 125I analogue of 8 was synthesized in order to evaluate the possibility of side-chain elimination under the assay conditions. Approximately 90% of [125I]-8 remained intact for up to 1 h under assay conditions.

UI MeSH Term Description Entries
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D047072 Aromatase Inhibitors Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. Aromatase Inhibitor,Inhibitor, Aromatase,Inhibitors, Aromatase

Related Publications

M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
July 1989, Journal of steroid biochemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
May 1993, Journal of medicinal chemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
June 1986, Journal of medicinal chemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
April 2001, Bioscience, biotechnology, and biochemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
May 1987, Journal of medicinal chemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
December 2021, Pharmaceuticals (Basel, Switzerland),
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
May 2011, Cancer biology & therapy,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
January 1988, Steroids,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
January 2015, Journal of agricultural and food chemistry,
M V Darby, and J A Lovett, and R W Brueggemeier, and M P Groziak, and R E Counsell
December 1982, Steroids,
Copied contents to your clipboard!